| Autor: |
Paoletti, R., Crosignani, P. G., Kenemans, P., Wegner, N. K., Jackson, A. S., Losordo, D. W. |
| Zdroj: |
Women's Health & Menopause; 1999, p59-66, 8p |
| Abstrakt: |
In spite of significant advances in technique and adjunctive medical treatment, restenosis after percutaneous coronary revascularization remains a major problem. Moreover, women have fared comparatively poorly after percutaneous transluminal coronary angioplasty (PTCA) with less long-term relief of symptoms and a trend towards reduced survival compared to men [1]. Interestingly, two recent retrospective studies have suggested that women who took estrogen replacement therapy (ERT) after their angioplasty had less restenosis [2] and better long-term outcome [3] than their nonestrogen taking counterparts. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
